Michael Brand, founder of Sensor100 noted "Sensors in Medicine 2013 is the first biosensor conference to be focused solely on medical applications, the area which is currently showing the most rapid advances in this technology sector"
Past News ReleasesRSS
London (PRWEB UK) 14 February 2013
Developments in bio-sensors, MEMS, microfluidics and nanotechnology now make it feasible to measure many clinically significant parameters quickly, inexpensively and without the need for highly qualified medical technologists. Clinical diagnosis is moving from the laboratory to the patient's bedside and into the home.
Sensors in Medicine 2013, which is the first bio-sensor conference focused solely on this application area, brings together leading academic researchers and the companies which are commercializing new clinical applications. The conference will feature technical sessions on:
Invited speakers include: Dr. Paru Deshpanke (imec, Belgium), Professor Tony Cass (Imperial College, UK), Professor Terence Risby (Johns Hopkins University, USA) and Professor Chris van Hoof (Imec and the University of Leuven, Belgium). The Future Technology session on 6th March features senior academic speakers from Imperial College and the University of Cambridge.
The Conference will take place in the Wellcome Collection, London, and will include a reception to be held in the Medicine Now Gallery, as well as a concluding panel discussion on the future of bio-sensors in medicine.
Sensors in Medicine 2013 is organized by Sensor100, an international network of people and organizations active in the development and commercialization of bio-sensors and chemo-sensors. Sensor100 publishes a monthly eNewsletter to its network.Sensor100, which was founded in 2011 by Dr. Michael Brand, is managed by Captum Capital Limited, a consulting company which specializes in the management of technology innovation in the life sciences.